SGA
Siguler Guff Advisers’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,369,170
| Closed | -$60.4M | – | 4 |
|
|
2024
Q4 | $60.4M | Sell |
2,369,170
-1,022,584
| -30% | -$26.1M | 30.11% | 2 |
|
|
2024
Q3 | $96M | Hold |
3,391,754
| – | – | 35.68% | 2 |
|
|
2024
Q2 | $89.4M | Hold |
3,391,754
| – | – | 38.31% | 2 |
|
|
2024
Q1 | $103M | Hold |
3,391,754
| – | – | 41.04% | 1 |
|
|
2023
Q4 | $95.3M | Hold |
3,391,754
| – | – | 38.07% | 2 |
|
|
2023
Q3 | $92.1M | Hold |
3,391,754
| – | – | 47.04% | 1 |
|
|
2023
Q2 | $104M | Hold |
3,391,754
| – | – | 46.16% | 1 |
|
|
2023
Q1 | $122M | Hold |
3,391,754
| – | – | 47.65% | 1 |
|
|
2022
Q4 | $134M | Sell |
3,391,754
-3,370,216
| -50% | -$133M | 64.43% | 1 |
|
|
2022
Q3 | $272M | Hold |
6,761,970
| – | – | 77.48% | 1 |
|
|
2022
Q2 | $284M | Hold |
6,761,970
| – | – | 69.86% | 1 |
|
|
2022
Q1 | $263M | Hold |
6,761,970
| – | – | 59.92% | 1 |
|
|
2021
Q4 | $269M | Hold |
6,761,970
| – | – | 56.37% | 1 |
|
|
2021
Q3 | $244M | Hold |
6,761,970
| – | – | 79.54% | 1 |
|
|
2021
Q2 | $277M | Hold |
6,761,970
| – | – | 82.55% | 1 |
|
|
2021
Q1 | $295M | Hold |
6,761,970
| – | – | 88.74% | 1 |
|
|
2020
Q4 | $338M | Buy |
+6,761,970
| New | +$338M | 92.73% | 1 |
|